STOCK TITAN
  1. Home
  2. Sec-filings
  3. ELV
  4. [Form 4] Elevance Health, Inc. Insider Trading Activity

Board member at Elevance Health (NYSE: ELV) receives 563 deferred stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

HAY LEWIS III reported acquisition or exercise transactions in this Form 4 filing.

Elevance Health director Hay Lewis III reported a grant of 563 shares of common stock in the form of deferred stock units. These units were awarded at a price of $0.00 per share as part of the company’s Board of Directors Compensation Program.

Following this award, Lewis directly holds 12,070 shares of Elevance Health common stock. The deferred stock units will be settled in company stock after five years from grant or when he leaves the board, unless he has elected a later payout date under the board’s deferred compensation plan.

Positive

  • None.

Negative

  • None.
Insider HAY LEWIS III
Role null
Type Security Shares Price Value
Grant/Award Common Stock 563 $0.00 --
Holdings After Transaction: Common Stock — 12,070 shares (Direct, null)
Footnotes (1)
  1. Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Deferred stock units granted 563 shares Grant to director Hay Lewis III on May 13, 2026
Grant price per share $0.00 per share Compensation award under board program
Shares held after transaction 12,070 shares Total direct holdings of Hay Lewis III following grant
Payout timing trigger 5 years from grant or board departure When deferred stock units are payable in company stock
Deferred stock units financial
"Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program."
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Board of Directors Compensation Program financial
"Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program."
Board of Directors Deferred Compensation Plan financial
"under the Company's Board of Directors Deferred Compensation Plan."
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HAY LEWIS III
(Last)(First)(Middle)
220 VIRGINIA AVENUE
(Street)
INDIANAPOLIS INDIANA 46204
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Elevance Health, Inc. [ ELV ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/13/2026A563(1)(2)A$012,070D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
2. The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Remarks:
/s/ Kathleen S. Kiefer, Attorney in fact05/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Elevance Health (ELV) director Hay Lewis III report on Form 4?

Hay Lewis III reported receiving 563 deferred stock units of Elevance Health common stock as a grant. The award was made at $0.00 per share under the company’s Board of Directors Compensation Program and increases his direct holdings to 12,070 shares.

How many Elevance Health shares does Hay Lewis III hold after this grant?

After the grant, Hay Lewis III directly holds 12,070 shares of Elevance Health common stock. This total includes the newly awarded 563 deferred stock units, which are part of the company’s standard compensation program for members of its board of directors.

What are the terms of the 563 deferred stock units granted by Elevance Health?

The 563 deferred stock units represent Elevance Health common stock payable in the future. They are scheduled to be paid in shares five years from the grant date or when Hay Lewis III leaves the board, unless he has chosen a later date under the board’s deferred compensation plan.

When will Hay Lewis III receive Elevance Health shares from these deferred stock units?

The deferred stock units will be paid in Elevance Health common stock upon the earlier of five years from the grant date or when Hay Lewis III ceases to serve on the board, unless he has elected a later distribution date under the Board of Directors Deferred Compensation Plan.

Is the 563-share award to Hay Lewis III an open-market purchase of Elevance Health stock?

No, the 563 shares are a grant of deferred stock units, not an open-market purchase. They were awarded at $0.00 per share as compensation under Elevance Health’s Board of Directors Compensation Program, with payment to occur in stock at a future date.